Emergency Medicine·Flushing, NY

New York-Presbyterian/Queens

Signal lift68%86%+18 pp with a signal here
Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
236–264
p10 – p90
Sample N
765
applicants this cycle
This cycle
no tracked aways yet
Match rate
1.3%
10 of 310 applicants
01Cohort funnelthis cycle
N = 765
Applied
765
100.0%
Invited
310
40.5%
Class size
10
1.3%
No visa sponsorshipCategoricalResearchAcademic/Clinician Educator
Your fitNew York-Presbyterian/Queens Program

Create a free profile to see your personalized fit

Get started
Contact
SP
Program Director
Saumil Harshad Parikh, MD
Email director
LH
Program Coordinator
Lily Hu
Email coordinator
Training sites1 site · Flushing
  • 1
    New York-Presbyterian/Queens
    Flushing, NY
    Primary
Score rangesinvited cohort
USMLE Step 2 CK236264
180205230255280
COMLEX Level 2 CE465664
400500600700800
Interview rates
US MD
67%
US DO
50%
US IMG
1%
Non-US IMG
0%
Applicant origin
In-state
65%
Out-of-state
34%
Interview prepEmergency Medicine
clinicalDescribe a time you had to make a critical decision quickly.★ common
clinicalHow do you handle uncertainty in diagnosis?★ common
behavioralWhat's your approach to a busy ED with multiple patients waiting?
programCommunity vs academic EM — what's your preference?
behavioralHow do you handle difficult patients or families?
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Community resourcesEmergency Medicine · 25-26
Save this program

Add New York-Presbyterian/Queens to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Emergency Medicine.

See how your profile compares across all programs.

Open calculator →

Data from NRMP 2025 Residency Explorer. Not medical advice. © 2026 Rezumab LLC.